Imaging left ventricular muscarinic receptor heterogeneity: A tool to evaluate individuals at risk for sudden death?

Circulation: Cardiovascular Imaging

Volumn 2, Issue 5, 2009, Pages 353-355

  Caldwell, James H ^a   Link, Jeanne M ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; (3 IODOBENZYL)GUANIDINE I 131; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; METHYLQUINUCLIDINYLBENZILATE C 11; MUSCARINIC M1 RECEPTOR; MUSCARINIC M2 RECEPTOR; MUSCARINIC M3 RECEPTOR; MUSCARINIC RECEPTOR; NORADRENALIN; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; CARBON; CLIDINIUM; DIAGNOSTIC AGENT; DRUG DERIVATIVE; LIGAND; MUSCARINIC RECEPTOR BLOCKING AGENT; QUINUCLIDINYL BENZILATE;

CARDIOVASCULAR RISK; CONTRAST ENHANCEMENT; EDITORIAL; HEART ARRHYTHMIA; HEART INFARCTION; HEART INNERVATION; HEART LEFT VENTRICLE; HEART RATE VARIABILITY; HEART VENTRICLE FIBRILLATION; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARASYMPATHETIC TONE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; RECEPTOR DENSITY; RECEPTOR UPREGULATION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SINUS RHYTHM; SUDDEN DEATH; CHEMISTRY; HEART MUSCLE; HEART RATE; HEART VENTRICLE; INNERVATION; METABOLISM; NOTE; PATHOLOGY; PATHOPHYSIOLOGY; PREDICTION AND FORECASTING; RISK ASSESSMENT; SCINTISCANNING; UPREGULATION; VAGUS NERVE;

CARBON RADIOISOTOPES; DEATH, SUDDEN, CARDIAC; HEART RATE; HEART VENTRICLES; HUMANS; LIGANDS; MAGNETIC RESONANCE IMAGING, CINE; MUSCARINIC ANTAGONISTS; MYOCARDIAL INFARCTION; MYOCARDIUM; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; QUINUCLIDINYL BENZILATE; RADIOPHARMACEUTICALS; RECEPTORS, MUSCARINIC; RISK ASSESSMENT; UP-REGULATION; VAGUS NERVE;

EID: 70350496811     PISSN: 19419651     EISSN: 19420080     Source Type: Journal    
DOI: 10.1161/CIRCIMAGING.109.900621     Document Type: Editorial

References (16)

1. Mazzadi AN, Pineau J, Costes N, Le Bars D, Bonnefoi F, Croisille P, Porcher R, Chevalier P. Muscarinic receptor upregulation in patients with myocardial infarction: a new paradigm. Circ Cardiovasc Imaging. 2009; 2:365-372.
2. Kleiger RE, Stein PK, Bigger JT Jr. Heart rate variability: measurement and clinical utility. Ann Noninvasive Electrocardiol. 2005;10:88-101.
3. Folino AF, Tokajuk B, Porta A, Romano S, Cerutti S, Volta SD. Autonomic modulation and clinical outcome in patients with chronic heart failure. Int J Cardiol. 2005;100:247-251.
4. Guzzetti S, Rovere MTL, Pinna GD, Maestri R, Borroni E, Porta A, Mortara A, Malliani A. Different spectral components of 24 h heart rate variability are related to different modes of death in chronic heart failure. Eur Heart J. 2005;26:357-362.
5. Kasanuki H, Ohnishi S, Ohtuka M, Matsuda N, Nirei T, Isogai R, Shoda M, Toyoshima Y, Hosoda S. Idiopathic ventricular fibrillation induced with vagal activity in patients without obvious heart disease. Circulation. 1997;95:2277-2285.
6. Tamaki S, Yamada T, Okuyama Y, Morita T, Sanada S, Tsukamoto Y, Masuda M, Okuda K, Iwasaki Y, Yasui T, Hori M, Fukunami M. Cardiac iodine-123 metaiodobenzylguanidine imaging predicts sudden cardiac death independently of left ventricular ejection fraction in patients with chronic heart failure and left ventricular systolic dysfunction: results from a comparative study with signal-averaged electrocardiogram, heart rate variability, and QT dispersion. J Am Coll Cardiol. 2009;53:426-435.
7. Caldwell JH, Link JM, Levy WC, Poole JE, Stratton JR. Evidence for preto postsynaptic mismatch of the cardiac sympathetic nervous system in ischemic congestive heart failure. J Nucl Med. 2008;49:234-241.
8. Maziere M, Comar D, Godot JM, Collard P, Cepeda C, Naquet R. In vivo characterization of myocardium muscarinic receptors by positron emission tomography. Life Sci. 1981;29:2391-2397.
9. Gibson RE, Eckelman WC, Vieras F, Reba RC. The distribution of the muscarinic acetylcholine receptor antagonists, quinuclidinyl benzilate and quinuclidinyl benzilate methiodide (both tritiated), in rat, guinea pig, and rabbit. J Nucl Med. 1979;20:865-870.
10. Motulsky HJ. PET receptors. Counting receptors using positron emission tomography. Circulation. 1990;82:1536-1538.
11. Delforge J, Le Guludec D, Syrota A, Bendriem B, Crouzel C, Slama M, Merlet P. Quantification of myocardial muscarinic receptors with PET in humans. J Nucl Med. 1993;34:981-991.
12. Delforge J, Janier M, Syrota A, Crouzel C, Vallois JM, Cayla J, Lancon JP, Mazoyer BM. Noninvasive quantification of muscarinic receptors in vivo with positron emission tomography in the dog heart. Circulation. 1990;82:1494-1504.
13. Marquetant R, Brehm B, Strasser RH. Chronic beta-blockade transregulates inhibitory A1 adenosine and muscarinic M2 receptors of the adenylyl cyclase system. J Mol Cell Cardiol. 1992;24:535-548.
14. Kim RJ, Fieno DS, Parrish TB, Harris K, Chen EL, Simonetti O, Bundy J, Finn JP, Klocke FJ, Judd RM. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation. 1999;100:1992-2002.
15. Traish AM, Kim N, Carson MP, de Tejada IS. Characterization of muscarinic acetylcholine receptors in cultured bovine aortic endothelial cells. J Recept Res. 1994;14:153-166.
16. Iizuka K, Sano H, Kawaguchi H, Kitabatake A. Transforming growth factor beta-1 modulates the number of beta-adrenergic receptors in cardiac fibroblasts. J Mol Cell Cardiol. 1994;26:435-440.